Conferences
#ESHCML2023

ESH-iCMLF 25th Annual John Goldman Conference on
Chronic Myeloid Leukemia: Biology and Therapy

‍

#ESHCML2023
Translational
October 6-8, 2023
-
Mandelieu-La Napoule, France

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, François-Xavier Mahon, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

ESH-iCMLF 25th Annual John Goldman Conference on
Chronic Myeloid Leukemia: Biology and Therapy

‍

Information

‍

ABOUT THE CONFERENCE:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

This educational conference has been approved for 18 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!

‍

SCIENTIFIC TOPICS:

• How I treat smoldering myeloma (SMM)
• How I treat newly diagnosed multiple myeloma
• From risk stratification to risk-based therapy?
• Should we use MRD testing to determine therapy in multiple myeloma?
• Is CAR T cell therapy replacing autologous SCT?
• How I treat relapsed multiple myeloma
• Cell free DNA / circulating tumor cells to replace BM-biopsy and MRD measurement
• You can’t be immune for immune therapy anymore
• The future of multiple myeloma
• Other plasma cell dyscrasias

‍

Program

Read the final program!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

Diamond Conference Partner
*******

‍

Emerald Conference Partner
*******

‍

Ruby Conference Partner
*******

‍

‍*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

‍

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences